Hepatic leiomyosarcoma: A case report

The authors present a review of pathogenesis, diagnosis and various approaches to treatment for an extremely rare tumor - primary hepatic leiomyosarcoma. This tumor is difficult to be diagnosed by imaging examinations. The prevalent method of treatment is a radical resection (R0 surgery). According to literature the median survival of patients with LMSL is about one year with DFS after treatment about 10 months. Also the authors describe a case report of the successful cure of middle-aged female with primary hepatic leiomyosarcoma and Hodgkin's lymphoma in the anamnesis. She has undergone 6 cycles of neoadjuvant chemotherapy with Ifosfamide and Doxorubicin. The tumour response was estimated as partial. Then patient has undergone radical surgery in the volume of extended left hemihepatectomy with LND. Follow-up examination 38 months after treatment revealed no progression of the disease.

Авторы
Ter-Ovanesov M.D. 1, 2 , Valkin D.L.2 , Gaboyan A.S. 1, 2 , Kukosh M.Yu. 1, 2 , Ronzin A.V.2 , Andrianova V.S.2 , Larin A.I.2 , Zhuk A.I.2
Журнал
Издательство
Izdatel'stvo Meditsina
Номер выпуска
6
Язык
Русский
Страницы
857-862
Статус
Опубликовано
Том
62
Год
2016
Организации
  • 1 Russian University of Peoples' Friendship, Moscow, Russian Federation
  • 2 City Clinical Hospital No40, Moscow, Russian Federation
Ключевые слова
Neoadjuvant chemotherapy; Primary hepatic leiomyosarcoma; Primary nonepithelial malignant tumors of the liver; Resection of the liver
Цитировать
Поделиться

Другие записи

Shneider Y.A., Smirnova I.P., Karimova E.V.
Бюллетень экспериментальной биологии и медицины Клеточные технологии в биологии и медицине. New York Consultants BureauSpringer / Автономная некоммерческая организация Издательство Российской академии медицинских наук. Том 162. 2016. С. 79-81